Expanding MOUD Access Through Correctional Telemedicine
Introduction
For decades, access to evidence-based addiction treatment has remained a significant challenge in U.S. jails and prisons. In practice, staffing shortages, rural geography, security limitations, and fragmented healthcare systems frequently prevent incarcerated individuals from receiving consistent medical care particularly treatment for opioid use disorder (OUD). As a result, many patients experience delays, interruptions, or complete gaps in care. However, telemedicine addiction treatment, including tele-MOUD (Medication for Opioid Use Disorder delivered via telehealth), is rapidly changing this reality.
Through secure telehealth platforms, telemedicine enables licensed physicians to deliver high-quality, compliant addiction care directly within correctional facilities and, importantly, to continue that care after release. When implemented correctly, tele-MOUD not only expands access but also strengthens continuity of care and significantly reduces overdose deaths during the most dangerous transition period. In this context, DevotedDOc does not view telemedicine as a workaround; rather, it is a clinically sound, scalable solution that treats OUD as the chronic medical condition it is. [1][2]
The Access Problem in Correctional Addiction Treatment
Correctional facilities house a population with extraordinarily high rates of substance use disorders. According to available estimates, nearly two-thirds of people in jail meet criteria for a substance use disorder. However, despite this high prevalence, only a small fraction receive FDA-approved medications such as buprenorphine or methadone. [1][3]
Several systemic barriers contribute to this gap:
- Limited on-site medical staff
- Difficulty recruiting addiction-trained physicians
- Rural or remote facility locations
- Security and transportation constraints
- Frequent disruptions in care during facility transfers or release
Telemedicine addiction treatment directly addresses these barriers by bringing medical expertise into facilities virtually without compromising clinical quality or regulatory compliance. [2][4]
What Is Tele-MOUD?
Tele-MOUD refers to the delivery of medications for opioid use disorder such as buprenorphine through telemedicine platforms. Care is provided by licensed physicians using secure, HIPAA-compliant technology. In correctional settings, tele-MOUD typically includes:
- Medical evaluation and diagnosis of OUD
- Buprenorphine prescribing and management
- Regular follow-up visits via video
- Coordination with on-site nursing or medical staff
- Transition planning for post-release care
Tele-MOUD is supported by federal guidance and peer-reviewed research demonstrating that outcomes are comparable to, and in some cases better than, traditional in-person care. [4][5]
Why Telemedicine Works in Correctional Settings
1. It Expands Access to Qualified Physicians
One of the biggest challenges correctional systems face is access to addiction-trained clinicians. Telemedicine allows facilities to connect incarcerated individuals with licensed physicians regardless of geography. This is especially important for rural jails and prisons that struggle to recruit on-site providers. [2][6]
With tele-MOUD, care is no longer limited by county lines or staffing shortages.
2. It Supports Timely Initiation of MOUD
Evidence-based correctional programs screen for OUD early, often at intake. Telemedicine allows facilities to initiate buprenorphine quickly, rather than waiting days or weeks for an on-site provider. Early initiation reduces withdrawal complications, improves engagement, and enhances facility safety. [1][3]
Timely treatment is a hallmark of high-performing correctional MAT programs.
3. It Maintains Continuity During Transfers and Release
Incarcerated individuals are frequently transferred between facilities or released with little notice. Tele-MOUD provides continuity across these transitions. Because care is not tied to a single physical location, treatment can continue without interruption before, during, and after release. [7][8]
Continuity of care is one of the strongest predictors of reduced overdose risk after incarceration. [9]
4. It Reduces Security and Logistical Burdens
Transporting individuals to off-site medical appointments requires staff time, vehicles, and security planning. Telemedicine eliminates many of these logistical challenges by delivering care within the facility. This reduces costs, improves scheduling efficiency, and minimizes security risks. [4][6]
From an operational standpoint, tele-MOUD is both efficient and cost-effective.
Telemedicine and Post-Release Overdose Prevention
The weeks following release from incarceration are the most dangerous period for people with OUD. Overdose risk during this time is 10 to 40 times higher than in the general population, and more than 100 times higher during the first two weeks. [8][9]
Telemedicine addiction treatment plays a critical role in preventing post-release overdose by:
- Allowing immediate follow-up visits after release
- Preserving buprenorphine treatment without gaps
- Reducing reliance on transportation or local provider availability
- Supporting individuals during housing or employment instability
Tele-MOUD ensures that treatment does not stop at the jail or prison gate. [7][9]
Addressing Common Concerns About Tele-MOUD
“Is Telemedicine as Effective as In-Person Care?”
Yes. Multiple studies have shown that telemedicine-based MOUD produces comparable outcomes to in-person treatment, including similar rates of retention, adherence, and reduction in illicit opioid use. [5][10]
“Is Tele-MOUD Safe in Correctional Settings?”
Tele-MOUD is delivered by licensed physicians following the same clinical standards used in traditional care. Medication administration and monitoring are coordinated with on-site medical staff, ensuring safety and accountability. [4][6]
“Does Telemedicine Increase Diversion Risk?”
In practice, concerns about diversion are often overstated. Moreover, buprenorphine’s design including its ceiling effect and naloxone component helps reduce the risk of misuse. In addition, structured protocols further limit misuse. Most importantly, evidence consistently shows that untreated opioid use disorder poses a far greater risk to safety than properly managed MOUD.[3][11]
Evidence Supporting Telemedicine Addiction Treatment
National organizations increasingly support telemedicine as a core component of correctional addiction care:
- SAMHSA recognizes telehealth as a key strategy for expanding MOUD access
- NIDA supports buprenorphine treatment delivered through telemedicine
- Peer-reviewed research links tele-MOUD to improved access and continuity
These endorsements reflect a growing consensus: telemedicine is not a compromise, it is a best practice. [2][4][10]
How Tele-MOUD Fits Into Evidence-Based Correctional MAT Programs
High-quality correctional MAT programs share several characteristics:
- Medical framing of OUD
- Access to FDA-approved medications
- Early screening and initiation
- Integrated behavioral health support
- Planned continuity after release
Telemedicine strengthens each of these elements by expanding provider access and reducing systemic barriers. [1][6][7]
How DevotedDOc Delivers Telemedicine Addiction Treatment
Within this model, DevotedDOc is a physician-led telehealth provider specializing in addiction treatment, including Suboxone-based MOUD. Our telemedicine model is designed to meet the unique needs of correctional systems and justice-involved populations.
Our approach includes:
- Licensed physician oversight
- Tele-MOUD delivered through secure platforms
- Rapid access to care during and after incarceration
- Coordination with correctional and reentry partners
- Stigma-free, medically grounded treatment
By extending care beyond facility walls, DevotedDOc helps close the most dangerous gaps in addiction treatment.
Operational and Community Benefits of Tele-MOUD
Importantly, telemedicine addiction treatment benefits more than individual patients. In addition, facilities and communities also see measurable gains, including:
- Reduced medical emergencies related to withdrawal
- Lower transportation and staffing costs
- Improved post-release outcomes
- Reduced recidivism and overdose deaths
In this way, tele-MOUD aligns correctional healthcare with public health goals while also supporting safer communities. [1][8][9]
The Future of Correctional Addiction Care
As correctional systems continue to modernize, telemedicine will, therefore, play an increasingly central role. In this context, tele-MOUD enables facilities to meet legal, ethical, and medical standards of care, as well as adapt to workforce and funding realities. As a result, programs that integrate telemedicine today are, in the long run, better positioned to deliver consistent, life-saving treatment.[2][6]
Conclusion: Expanding Care Beyond Walls Saves Lives
Overall, telemedicine addiction treatment is, therefore, transforming how correctional systems address opioid use disorder. In particular, by expanding access, strengthening continuity of care, and supporting reentry, tele-MOUD directly addresses the most dangerous gaps in treatment. As the evidence consistently shows, and in fact confirms, when care continues beyond facility walls, lives are saved.
Treating OUD as a chronic medical condition does not end at incarceration and telemedicine makes that continuity possible. [7][9]
Call to Action: Partner or Refer
For facilities and organizations: DevotedDOc supports correctional systems, courts, re-entry nonprofits, and public health stakeholders with physician-led MOUD models and scalable continuity workflows.
For families and supporters, in addition, support is available for those who wish to help someone begin treatment through DevotedDOc’s donation pathway:
https://devoteddoc.com/donate/
Medically Reviewed By
References
- National Sheriff’s Association. Jail-Based Medication-Assisted Treatment. October 2018.
- Substance Abuse and Mental Health Services Administration. Breaking the Cycle: MAT in the Criminal Justice System. March 2019.
- National Institute on Drug Abuse. Effective Treatments for Opioid Addiction. November 2016.
- SAMHSA. Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders.
- JAMA Network Open. Telemedicine for Opioid Use Disorder Treatment Outcomes.
- National Council for Mental Wellbeing. MAT for OUD in Jails and Prisons Toolkit. February 2022.
- World Health Organization. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence.
- American Civil Liberties Union. Over-Jailed and Un-Treated. 2021.
- Addiction Science & Clinical Practice. Post-Release Opioid-Related Overdose Risk. April 2019.
- NIDA. Telehealth and Opioid Use Disorder Treatment.
- NIDA. Is MOUD Replacing One Addiction With Another? January 2018.
